Anti-GPD1 antibodies are used in the immunodetection of the protein glycerol-3-phosphate dehydrogenase 1. In humans, the canonical protein has a reported length of 349 amino acid residues and a mass of 37.6 kDa. Its subcellular localization is in the cytoplasm. Up to 2 different isoforms have been reported for this protein. It is notably expressed in the liver. A member of the NAD-dependent glycerol-3-phosphate dehydrogenase protein family, Gpd1 is known to have glycerol-3-phosphate dehydrogenase activity. The GPD1 gene has been associated with the disease, Hypertriglyceridemia. Synonyms for this target antigen include GPDH-C, HTGTI, glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic, epididymis secretory sperm binding protein, and GPD-C. GPD1 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. A number of Gpd1 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.